Prediction of Long-Term Diabetes Remission After Metabolic Surgery in Obese East Asian Patients: a Comparison Between ABCD and IMS Scores
Authors:
- Masayuki OhtaMOMasayuki Ohta
- Yosuke SekiYSYosuke Seki
- Tetsuji OhyamaTOTetsuji Ohyama
- Rixing BaiRBRixing Bai
- Sang Hyun KimSKSang Hyun Kim
- Takashi OshiroTOTakashi Oshiro
- Tao JiangTJTao Jiang
- Akira SasakiASAkira Sasaki
- Takeshi NaitohTNTakeshi Naitoh
- Tsuyoshi YamaguchiTYTsuyoshi Yamaguchi
- Susumu InamineSISusumu Inamine
- Yasuhiro MiyazakiYMYasuhiro Miyazaki
- 7 January 2021
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 31 (4) , 1485-1495
Abstract
Purpose Recently, more than 10 models have been developed to predict remission of type 2 diabetes mellitus (T2DM) after metabolic surgery. The ABCD score was compared to the individualized metabolic surgery (IMS) score in terms of prediction of T2DM remission, but which of the two scoring systems is better remains controversial. Methods Patient data from 463 obese East Asian patients who underwent laparoscopic Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), or SG with duodenojejunal bypass (SG-DJB) as a primary operation and were followed for at least 3 years were retrospectively collected from 24 institutions. The correlation between the ABCD and IMS scoring systems and the discrimination power of the models was evaluated. The cut-off point for the IMS stage of T2DM severity was also revised to adjust the scoring system to obese East Asian patients. Results The two scoring systems were significantly well correlated. The IMS scoring system showed significant differences in T2DM remission rates between the procedures in the moderate stage, but the ABCD score showed no significant differences in each category. The discrimination power of the IMS score was comparable to that of the ABCD score at both 3 and 5 years. The revised IMS scoring system showed that SG-DJB had significantly higher T2DM remission rates in the moderate stage at 5 years than RYGB or SG. Conclusion IMS score may be comparable to ABCD score to predict T2DM remission in obese East Asian patients. The revised IMS scoring system may also select candidates for SG or SG-DJB.Keywords
This publication has 23 references indexed in Scilit:
- Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m2, First Year ResultsObesity Surgery, 2016
- Laparoscopic sleeve gastrectomy for type 2 diabetes mellitus: predicting the success by ABCD scoreSurgery for Obesity and Related Diseases, 2015
- Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric BypassObesity Surgery, 2015
- Standardized outcomes reporting in metabolic and bariatric surgerySurgery for Obesity and Related Diseases, 2015
- Laparoscopic Sleeve Gastrectomy Versus Single Anastomosis (Mini-) Gastric Bypass for the Treatment of Type 2 Diabetes Mellitus: 5-Year Results of a Randomized Trial and Study of Incretin EffectObesity Surgery, 2014
- Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort studyThe Lancet Diabetes & Endocrinology, 2014
- Laparoscopic Single-Anastomosis Duodenal–Jejunal Bypass with Sleeve Gastrectomy (SADJB-SG): Short-term Result and Comparison with Gastric BypassObesity Surgery, 2013
- Gastric bypass in Type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomesDiabetic Medicine, 2012
- Fibronectin Gene Expression in Human Adipose Tissue and Its Associations with Obesity-Related Genes and Metabolic ParametersObesity Surgery, 2012
- Predicting the Glycemic Response to Gastric Bypass Surgery in Patients With Type 2 DiabetesDiabetes Care, 2012